Eribulin Mesylate
Products in Health Canada’s databases that list Eribulin Mesylate as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 5
- 5 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 11
- Products in all
- 5
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| ERIBULIN MESYLATE INJECTION (0.5 MG) | 02545950 | Marketed | Dr Reddy's Laboratories Ltd | |
| HALAVEN (0.5 MG) | 02377438 | Marketed | Eisai Limited | |
| ERIBULIN MESYLATE INJECTION (0.5 MG) | 02560399 | Approved | Baxter Corporation | |
| ERIBULIN MESYLATE INJECTION (0.5 MG) | 02564467 | Approved | Marcan Pharmaceuticals Inc. | |
| NAT-ERIBULIN (0.5 MG) | 02539136 | Dormant | Natco Pharma (Canada) Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- ERIBULIN MESYLATE INJECTIONJanuary 9, 2026 · NOC 36712
- ERIBULIN MESYLATE INJECTIONOctober 10, 2025 · NOC 36152
- HALAVENAugust 21, 2025 · NOC 35879
- ERIBULIN MESYLATE INJECTIONMarch 4, 2024 · NOC 32813
- NAT-ERIBULINJune 27, 2023 · NOC 31058
- HALAVENJanuary 15, 2019 · NOC 21749
- HALAVENNovember 3, 2017 · NOC 20001
- HALAVENAugust 4, 2017 · NOC 19635
- HALAVENJuly 21, 2017 · NOC 19551
- HALAVENSeptember 7, 2012 · NOC 13656
- HALAVENDecember 14, 2011 · NOC 12871